Sagespring Wealth Partners LLC Takes $961,000 Position in STERIS plc (NYSE:STE)

Sagespring Wealth Partners LLC acquired a new stake in STERIS plc (NYSE:STE - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 4,677 shares of the medical equipment provider's stock, valued at approximately $961,000.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Avalon Trust Co acquired a new stake in STERIS during the 4th quarter valued at $30,000. Human Investing LLC acquired a new position in shares of STERIS in the fourth quarter valued at $31,000. Anfield Capital Management LLC raised its position in shares of STERIS by 100.0% in the fourth quarter. Anfield Capital Management LLC now owns 182 shares of the medical equipment provider's stock valued at $37,000 after purchasing an additional 91 shares during the period. Central Pacific Bank Trust Division boosted its holdings in shares of STERIS by 65.5% during the 4th quarter. Central Pacific Bank Trust Division now owns 192 shares of the medical equipment provider's stock worth $39,000 after buying an additional 76 shares during the period. Finally, Manchester Capital Management LLC grew its stake in STERIS by 182.7% in the 4th quarter. Manchester Capital Management LLC now owns 212 shares of the medical equipment provider's stock valued at $44,000 after buying an additional 137 shares during the last quarter. 94.69% of the stock is currently owned by institutional investors.

STERIS Price Performance

Shares of NYSE:STE traded up $2.51 during trading on Friday, reaching $222.53. 451,315 shares of the company traded hands, compared to its average volume of 527,798. The firm has a market capitalization of $21.86 billion, a PE ratio of 47.25 and a beta of 0.87. STERIS plc has a 52 week low of $197.84 and a 52 week high of $248.24. The company has a quick ratio of 1.40, a current ratio of 2.13 and a debt-to-equity ratio of 0.32. The company's 50 day moving average is $222.48 and its two-hundred day moving average is $219.19.

STERIS (NYSE:STE - Get Free Report) last posted its quarterly earnings data on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share for the quarter, missing the consensus estimate of $2.33 by ($0.01). STERIS had a return on equity of 13.91% and a net margin of 8.66%. As a group, sell-side analysts predict that STERIS plc will post 9.08 earnings per share for the current year.

STERIS Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, March 21st. Investors of record on Thursday, February 20th were given a dividend of $0.57 per share. The ex-dividend date of this dividend was Thursday, February 20th. This represents a $2.28 annualized dividend and a dividend yield of 1.02%. STERIS's dividend payout ratio is 48.41%.

Analyst Ratings Changes

STE has been the subject of several research reports. JMP Securities restated a "market outperform" rating and set a $265.00 price objective on shares of STERIS in a research report on Thursday, April 10th. Piper Sandler boosted their price target on STERIS from $260.00 to $265.00 and gave the company an "overweight" rating in a research note on Monday, February 3rd. Needham & Company LLC reiterated a "hold" rating on shares of STERIS in a research report on Monday, April 7th. Finally, Stephens reissued an "overweight" rating and issued a $240.00 target price on shares of STERIS in a research report on Thursday, February 6th. One analyst has rated the stock with a hold rating and five have issued a buy rating to the company's stock. According to MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus price target of $258.75.

STERIS Company Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.